Medtronic InSync ICD Strength, Market Growth Propel Third-Quarter Sales
This article was originally published in The Gray Sheet
Executive Summary
Medtronic says that its congestive heart failure business is annualizing at well over $500 mil. based on second fiscal quarter sales